Vascular endothelial growth factor corrected for platelet count and hematocrit is associated with the clinical course of aplastic anemia in children
International Journal of Hematology, 05/02/2012
Kodama Y et al. – The data indicate that a compensatory mechanism for increasing vascular endothelial growth factor (VEGF) and preventing disease progression might play a role in aplastic anemia (AA). Corrected VEGF may be useful for predicting the clinical course of AA.